A Second-Order Fast Discharge Circuit for Transient Electromagnetic Transmitter. [PDF]
Tan C, Yuan S, Yu L, Chen Y, He C.
europepmc +1 more source
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai +28 more
wiley +1 more source
Analyzing Riemann-Liouville constraints in second-order Lagrangian fractional electrodynamic models. [PDF]
Alawaideh YM, Al-Khamiseh BM, Adu IK.
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Adaptive neural network based leader-following consensus control for a class of second-order nonlinear multi-agent systems. [PDF]
Al Samman FM +4 more
europepmc +1 more source
Second Order Regression with Two Predictor Variables Centered on Mean in an Ill Conditioned Model
Ijomah Maxwell Azubuike
openalex +1 more source
Chronological and Spatial Distribution of Skeletal Muscle Fat Replacement in FHL1‐Related Myopathies
ABSTRACT Objectives Variants in the FHL1 gene cause FHL1‐related myopathies (FHL1‐RMs), a group of neuromuscular disorders with diverse clinical presentations. This study aimed to comprehensively characterize the spatial and temporal patterns of skeletal muscle fat replacement throughout the whole body in FHL1‐RMs, to examine disease progression over ...
Rui Shimazaki +8 more
wiley +1 more source
Second-Order Effects in Lightweight Aggregate Concrete Slender Columns. [PDF]
Kołodziejczyk E +4 more
europepmc +1 more source
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
Development and validation of the socially shared regulated learning questionnaire: insights from a second-order confirmatory factor analysis. [PDF]
Yang Y, He Z, Wei Y, Tang E.
europepmc +1 more source

